Loading...
XSHE300596
Market cap837mUSD
Jan 10, Last price  
26.74CNY
1D
-4.16%
1Q
-4.16%
IPO
124.14%
Name

Rianlon Corp

Chart & Performance

D1W1MN
XSHE:300596 chart
P/E
16.94
P/S
1.17
EPS
1.58
Div Yield, %
2.34%
Shrs. gr., 5y
4.94%
Rev. gr., 5y
28.65%
Revenues
5.24b
+8.26%
261,812,133319,939,628403,912,800488,129,700604,731,953808,312,7271,142,409,9131,487,749,3261,978,311,4862,482,787,1343,444,636,1274,842,783,5455,242,567,593
Net income
362m
-31.05%
19,721,41035,196,91640,034,45045,134,62473,682,75590,577,461130,500,277193,073,521262,314,192292,993,191417,594,673525,718,826362,486,514
CFO
173m
-66.40%
16,663,00011,090,70017,693,38934,054,00880,715,74523,995,64331,396,41335,004,145165,973,519186,979,247312,125,695513,847,807172,628,331
Dividend
Jul 02, 20240.344 CNY/sh
Earnings
May 13, 2025

Profile

Rianlon Corporation provides anti-aging additives and application technologies for polymeric materials industry worldwide. It offers primary and secondary antioxidants, UV absorbers, hindered amine light stabilizers (HALS), and antioxidant U-pack, which is customized blending formulation to provide anti-aging solution. The company's products are used in automotive parts, coating, construction materials, packaging, electronics, housewares, etc. Rianlon Corporation was founded in 1994 and is headquartered in Tianjin, China.
URL
https://www.rianlon.com/en/
IPO date
Jan 19, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
5,242,568
8.26%
4,842,784
40.59%
Cost of revenue
4,623,102
4,041,261
Unusual Expense (Income)
NOPBT
619,466
801,523
NOPBT Margin
11.82%
16.55%
Operating Taxes
50,603
55,992
Tax Rate
8.17%
6.99%
NOPAT
568,863
745,531
Net income
362,487
-31.05%
525,719
25.89%
Dividends
(143,546)
(62,733)
Dividend yield
2.11%
0.52%
Proceeds from repurchase of equity
(17,447)
BB yield
0.15%
Debt
Debt current
565,925
688,228
Long-term debt
1,182,449
1,104,461
Deferred revenue
45,071
33,502
Other long-term liabilities
44
Net debt
702,193
972,939
Cash flow
Cash from operating activities
172,628
513,848
CAPEX
(573,669)
Cash from investing activities
(620,977)
Cash from financing activities
687,222
258,491
FCF
435,831
(219,218)
Balance
Cash
1,039,989
859,366
Long term investments
6,192
(39,616)
Excess cash
784,053
577,610
Stockholders' equity
2,464,532
2,221,046
Invested Capital
5,286,153
5,145,109
ROIC
10.91%
16.64%
ROCE
10.14%
13.93%
EV
Common stock shares outstanding
229,620
219,369
Price
29.61
-45.74%
54.57
21.92%
Market cap
6,799,038
-43.20%
11,970,989
30.46%
EV
7,674,145
13,055,413
EBITDA
908,883
1,031,461
EV/EBITDA
8.44
12.66
Interest
60,833
44,944
Interest/NOPBT
9.82%
5.61%